Dec 9 (Reuters) - Botanix Pharmaceuticals Ltd BOT.AX :
* BOTANIX PHARMACEUTICALS LTD ANNOUNCES RECEIPT OF ETHICS APPROVAL FOR ITS PLANNED BTX 1702 PHASE 1B CLINICAL STUDY
* BOTANIX PHARMACEUTICALS LTD - CLINICAL STUDY IS FOR TREATMENT OF PAPULOPUSTULAR ROSACEA AND AN EXPANSION OF STUDY DESIGN